5 Most Profitable Biotech Stocks To Invest In

Page 5 of 5

1. Johnson & Johnson (NYSE:JNJ)

Number of Q4 2023 Hedge Fund Shareholders: 28

Latest TTM Net Income: $35.1 billion

Johnson & Johnson (NYSE:JNJ) is the well heeled American healthcare and general wellness company based in New Jersey. It also owns a variety of biotechnology companies in its portfolio, with the most notable one being the former Janssen Pharma. This hasn’t stopped Johnson & Johnson (NYSE:JNJ) from expanding though, as it revealed in December 2023 that it will buy a biotech company focusing on cancer treatments for a $2 billion price tag.

81 out of the 933 hedge funds tracked by Insider Monkey had invested in Johnson & Johnson (NYSE:JNJ) as of Q4 2023 end. Ken Fisher’s Fisher Asset Management owned the biggest stake which was worth $995 million.

Follow Johnson & Johnson (NYSE:JNJ)

Disclosure: None. You can also take a look at 11 Best Small Cap Pharma Stocks to Invest In and 20 Healthiest States in the US in 2023.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter

Page 5 of 5